Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CORTICOSTEROID NOS Cause Condition aggravated? 24 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 24 reports of Condition aggravated have been filed in association with CORTICOSTEROID NOS. This represents 3.2% of all adverse event reports for CORTICOSTEROID NOS.

24
Reports of Condition aggravated with CORTICOSTEROID NOS
3.2%
of all CORTICOSTEROID NOS reports
7
Deaths
13
Hospitalizations

How Dangerous Is Condition aggravated From CORTICOSTEROID NOS?

Of the 24 reports, 7 (29.2%) resulted in death, 13 (54.2%) required hospitalization, and 3 (12.5%) were considered life-threatening.

Is Condition aggravated Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CORTICOSTEROID NOS. However, 24 reports have been filed with the FAERS database.

What Other Side Effects Does CORTICOSTEROID NOS Cause?

Off label use (89) Drug ineffective (80) Drug ineffective for unapproved indication (46) Pyrexia (42) Product use in unapproved indication (29) Pain (26) Diarrhoea (25) Fatigue (25) Sepsis (24) Cytomegalovirus infection (22)

What Other Drugs Cause Condition aggravated?

TOFACITINIB (16,925) INFLIXIMAB (16,616) DUPILUMAB (16,459) ETANERCEPT (15,897) METHOTREXATE (14,938) ADALIMUMAB (13,527) PREDNISONE (10,751) INFLIXIMAB-DYYB (10,275) HYDROXYCHLOROQUINE (8,848) RITUXIMAB (8,627)

Which CORTICOSTEROID NOS Alternatives Have Lower Condition aggravated Risk?

CORTICOSTEROID NOS vs CORTICOTROPIN CORTICOSTEROID NOS vs CORTISONE CORTICOSTEROID NOS vs CORTISONE\HYDROCORTISONE CORTICOSTEROID NOS vs COSMETICS CORTICOSTEROID NOS vs COUMADIN

Related Pages

CORTICOSTEROID NOS Full Profile All Condition aggravated Reports All Drugs Causing Condition aggravated CORTICOSTEROID NOS Demographics